GDx Staging System is successful in RNFL damage classification

Article

The GDx Staging System is an efficient way to interpret retinal fibre layer (RNFL) damage.

The GDx Staging System is an efficient way to interpret retinal fibre layer (RNFL) damage, according to a study published in the Journal of Glaucoma.

Dr Paolo Brusini et al., Department of Ophthalmology, Azienda Ospedaliero-Universitaria, Udine, Italy, conducted 320 GDx VCC tests on 84 healthy patients and 236 patients suffering from ocular hypertension or chronic open angle glaucoma. Additionally, the sensitivity and specificity of the GDx was measured in 161 patients with ocular hypertension or chronic open angle glaucoma and 34 normal patients.

The findings showed that sensitivity and the specificity of the GDx were significantly high at 88.2% and 100%, respectively. The results of clinical classification of glaucoma and the Glaucoma Staging System 2 were strongly correlated.

The GDx Staging System is a quick and effective method for classifying RNFL damage, especially for inexperienced ophthalmologists.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.